OCC 20.9% 66.5¢ orthocell limited

Ann: Successful OrthoATI clinical trial, page-12

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 261 Posts.
    lightbulb Created with Sketch. 181
    Not necessarily we ditched J&J, but it is good to have more options as this will help the Orthocell management negotiate a better deal with J&J or any other interested party
 
watchlist Created with Sketch. Add OCC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.